Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years due to Washington's insistence on sensitive information.
This rejection became public after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government spokesperson has since stated that the US was demanding access to biological samples for research and commercial purposes while was unwilling to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for more talks to secure a agreement agreeable to both sides so the nation's critical HIV programme can continue.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our people should a new disease outbreak arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the global health body and its push of one-on-one deals were disrupting frameworks previously set up via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body stated it acknowledged the government's concerns, but urged that talks must proceed since a large portion of the country's HIV programmes were funded by external financing.
"If specific concerns exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group commented.
The situation emphasises the continuing challenges between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.